Search global stocks & ETFs...Ctrl K
Learn Mode
Elevance Health IncELV
$393.44
$11.21 (2.933%)
$392.90
-$0.54 (-0.136%)
ELV
Stock Profile
10-19
Recommended Metric
Score Card
Explore Scores Tab
3.21
Average
Valuation Score
Key Score
2.00
Bad
Management
4.00
Good
Growth
1.00
Very Bad
Profitability
1.00
Very Bad
Fin. Health
2.00
Bad
Dividends
4.00
Good
Analyst
4.00
Good
Insider Transactions
Explore Insider Tab ›No prices were found for the time span selected.
Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
$393.44
Baseline
High
$522.90
▲
32.90%
Avg
$424.65
▲
7.93%
Low
$334.31
▼
-15.03%
Analyst Ratings based on 29 Analysts
Strong Buy
621%
Buy
1241%
Hold
1138%
Sell
000%
Strong Sell
000%
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.Read More